Researchers have found the anti-hormone treatment, tamoxifen, may be useful in the fight against mesothelioma. Traditionally used as a hormonal treatment for breast cancer, tamoxifen works by blocking the production of estrogen in breast cancer patients and is used as a treatment and preventative measure.
A recent lab study showed that although mesothelioma was not affected by the estrogen-blocking properties of the drug (which is sold under the brand names of Nolvadex or Soltamox), the drug blocked the growth of malignant pleural mesothelioma cells grown in a dish.
The study by researchers at the Beaumont Hospital in Dublin, Ireland, found the drug also worked in combination with chemotherapy to block the growth of the mesothelioma cancer cells. Find out more about this study here.
Mesothelioma Research News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.